Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Intracoronary infusion of selected autologous bone marrow stem cells improves longitudinal myocardial strain and strain rate in patients with old anterior myocardial infarction without recent revascularization.

Karatasakis G, Leontiadis E, Peristeri I, Manginas A, Goussetis E, Graphakos S, Papadakis E, Cokkinos DV.

Eur J Echocardiogr. 2010 Jun;11(5):440-5. doi: 10.1093/ejechocard/jep235. Epub 2010 Mar 22.

PMID:
20308191
2.

Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.

Manginas A, Goussetis E, Koutelou M, Karatasakis G, Peristeri I, Theodorakos A, Leontiadis E, Plessas N, Theodosaki M, Graphakos S, Cokkinos DV.

Catheter Cardiovasc Interv. 2007 May 1;69(6):773-81.

PMID:
17394248
3.

Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.

Turan RG, Bozdag-Turan I, Ortak J, Akin I, Kische S, Schneider H, Turan CH, Rehders TC, Rauchhaus M, Kleinfeldt T, Adolph E, Brehm M, Yokus S, Steiner S, Sahin K, Nienaber CA, Ince H.

Stem Cells Dev. 2011 Sep;20(9):1491-501. doi: 10.1089/scd.2010.0373. Epub 2010 Dec 29.

4.

COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.

Mansour S, Roy DC, Bouchard V, Nguyen BK, Stevens LM, Gobeil F, Rivard A, Leclerc G, Reeves F, Noiseux N.

J Cardiovasc Transl Res. 2010 Apr;3(2):153-9. doi: 10.1007/s12265-009-9145-2. Epub 2009 Nov 12.

PMID:
20560029
5.

Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study.

Herbots L, D'hooge J, Eroglu E, Thijs D, Ganame J, Claus P, Dubois C, Theunissen K, Bogaert J, Dens J, Kalantzi M, Dymarkowski S, Bijnens B, Belmans A, Boogaerts M, Sutherland G, Van de Werf F, Rademakers F, Janssens S.

Eur Heart J. 2009 Mar;30(6):662-70. doi: 10.1093/eurheartj/ehn532. Epub 2008 Dec 23.

PMID:
19106196
6.

Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging.

Ruan W, Pan CZ, Huang GQ, Li YL, Ge JB, Shu XH.

Chin Med J (Engl). 2005 Jul 20;118(14):1175-81. Erratum in: Chin Med J (Engl). 2005 Nov 20;118(22):1906.

PMID:
16117862
7.

How to measure the effects of the intracoronary stem cell therapy?

Tendera M, Wojakowski W.

Eur J Echocardiogr. 2010 Jun;11(5):438-9. doi: 10.1093/ejechocard/jeq025. Epub 2010 Mar 22.

PMID:
20308192
8.

Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.

Yao K, Huang R, Qian J, Cui J, Ge L, Li Y, Zhang F, Shi H, Huang D, Zhang S, Sun A, Zou Y, Ge J.

Heart. 2008 Sep;94(9):1147-53. doi: 10.1136/hrt.2007.137919. Epub 2008 Apr 1.

PMID:
18381377
9.

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.

Tendera M, Wojakowski W, Ruzyłło W, Chojnowska L, Kepka C, Tracz W, Musiałek P, Piwowarska W, Nessler J, Buszman P, Grajek S, Breborowicz P, Majka M, Ratajczak MZ; REGENT Investigators.

Eur Heart J. 2009 Jun;30(11):1313-21. doi: 10.1093/eurheartj/ehp073. Epub 2009 Feb 10.

PMID:
19208649
10.

Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience.

Limsuwan A, Pienvichit P, Limpijankit T, Khowsathit P, Hongeng S, Pornkul R, Siripornpitak S, Boonbaichaiyapruk S.

Clin Cardiol. 2010 Aug;33(8):E7-12. doi: 10.1002/clc.20463.

11.

Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.

Flores-Ramírez R, Uribe-Longoria A, Rangel-Fuentes MM, Gutiérrez-Fajardo P, Salazar-Riojas R, Cervantes-García D, Treviño-Ortiz JH, Benavides-Chereti GJ, Espinosa-Oliveros LP, Limón-Rodríguez RH, Monreal-Puente R, González-Treviño JL, Rojas-Martínez A.

Cardiovasc Revasc Med. 2010 Apr-Jun;11(2):72-8. doi: 10.1016/j.carrev.2009.04.001.

PMID:
20347795
12.

Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction.

Plewka M, Krzemińska-Pakuła M, Lipiec P, Peruga JZ, Jezewski T, Kidawa M, Wierzbowska-Drabik K, Korycka A, Robak T, Kasprzak JD.

Am J Cardiol. 2009 Nov 15;104(10):1336-42. doi: 10.1016/j.amjcard.2009.06.057. Epub 2009 Sep 25.

PMID:
19892047
13.

Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.

Chen SL, Fang WW, Qian J, Ye F, Liu YH, Shan SJ, Zhang JJ, Lin S, Liao LM, Zhao RC.

Chin Med J (Engl). 2004 Oct;117(10):1443-8. Erratum in: Chin Med J (Engl). 2005 Jan 5;118(1):88.

PMID:
15498362
14.

Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution.

Goussetis E, Manginas A, Koutelou M, Peristeri I, Theodosaki M, Kollaros N, Leontiadis E, Theodorakos A, Paterakis G, Karatasakis G, Cokkinos DV, Graphakos S.

Stem Cells. 2006 Oct;24(10):2279-83. Epub 2006 Jun 22.

15.

Stem cell therapy for the broken heart: mini-organ transplantation.

Mansour S, Roy DC, Lemieux B, Ouellet C, Stevens LM, Noiseux N.

Transplant Proc. 2009 Oct;41(8):3353-7. doi: 10.1016/j.transproceed.2009.08.033.

PMID:
19857748
16.

Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: quantum of initial necrosis is the key.

Obradović S, Balint B, Romanovic R, Trifunović Z, Rusović S, Baskot B, Dopudja M, Trifunović G, Rafajlovski S, Jung R, Gligić B.

Vojnosanit Pregl. 2009 Dec;66(12):998-1004.

PMID:
20095521
17.

Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.

Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, Van Haute I, Lootens N, Heyndrickx G, Wijns W.

Circulation. 2005 Aug 30;112(9 Suppl):I178-83.

18.

A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.

Yang Z, Zhang F, Ma W, Chen B, Zhou F, Xu Z, Zhang Y, Zhang D, Zhu T, Wang L, Wang H, Ding Z, Zhang Y.

Cardiovasc Ther. 2010 Dec;28(6):380-5. doi: 10.1111/j.1755-5922.2009.00116.x.

PMID:
20337639
19.

Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.

Yerebakan C, Kaminski A, Westphal B, Donndorf P, Glass A, Liebold A, Stamm C, Steinhoff G.

J Thorac Cardiovasc Surg. 2011 Dec;142(6):1530-9.e3. doi: 10.1016/j.jtcvs.2011.05.002. Epub 2011 Jun 12.

20.

Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.

Hirsch A, Nijveldt R, van der Vleuten PA, Tio RA, van der Giessen WJ, Marques KM, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Biemond BJ, Tijssen JG, van Rossum AC, Piek JJ, Zijlstra F.

Catheter Cardiovasc Interv. 2008 Feb 15;71(3):273-81. doi: 10.1002/ccd.21337.

PMID:
18288734

Supplemental Content

Support Center